Acquisition of Convenção Presidential approva...
12 July 2011
Tullett Prebon plc
Brazil: Acquisition of Convenção- Presidential approval obtained
Tullett Prebon plc (the "Company") announces that it has received notice that
it has been granted approval from the President of Brazil to acquire Convenção
S/A Corretora de Valores e Cambio ("Convenção"), one of the leading and most
respected inter-dealer brokers in Brazil.
The Company announced on 13 October 2009 that it had reached agreement to
acquire Convenção, conditional on receiving approval from the Brazilian
authorities. Obtaining Presidential approval was the final approval
outstanding. The terms of the acquisition remain unchanged.
The Company expects to complete the acquisition in August.
-ENDS-
For further information please contact:
Investors and Analysts
Nigel Szembel
Tullett Prebon plc
+44 207 200 7722
nszembel@tullettprebon.com
Press - Corporate and UK
Charlotte Kirkham
M:Communications
+44 207 920 2331
kirkham@mcomgroup.com
Press - United States of America
Bill Blase
W.T Blase & Associates
+ 1 212 221 1079
info@wtblase.com
Press-São Paulo
Uilson Paiva
Comunicação+
+ 55 11 7898 7820 / +55 11 3874 2031
uilson.paiva@comunicacaomais.com.br
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.